Quarterly report pursuant to Section 13 or 15(d)

Note 4 - Investment in account receivable

v3.20.2
Note 4 - Investment in account receivable
9 Months Ended
Sep. 30, 2020
Notes  
Note 4 - Investment in account receivable

Note 4 – Investment in account receivable

 

On April 10, 2015, the Company entered into an exchange agreement whereby the Company received an investment in an account receivable with annual installment payments of $117,000 for 11 years, through 2026, totaling $1,287,000 in exchange for 757,059 shares of Mentor Common Stock obtained through exercise of 757,059 Series D warrants at $1.60 per share plus a $0.10 per warrant redemption price.

 

The Company valued the transaction based on the market value of Company common shares exchanged in the transaction, resulting in a 17.87% discount from the face value of the account receivable. The discount is being amortized monthly to interest over the 11-year term of the agreement. The investment in account receivable is supported by an exchange agreement and consisted of the following:

 

 

 

September 30,

2020

 

December 31,

2019

Face value

$

702,000

$

706,000

Unamortized discount

 

(258,580)

 

(320,488)

Net balance

 

443,420

 

385,512

Current portion

 

(117,000)

 

(4,000)

Long term portion

$

326,420

$

381,512

 

For the three months ended September 30, 2020 and 2019, $23,691 and $19,999 of discount amortization is included in interest income, respectively. For the nine months ended September 30, 2020 and 2019, $61,908 and $59,996 of discount amortization is included in interest income, respectively.